PreDxion Bio YC Application
PreDxion Bio went through Y Combinator in the Summer 2017 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2017
- Industry
- HealthcareDiagnostics
- Team size
- 6
- Status
- Inactive
- Launched
- 2017
Founders
Walker McHughFounder
Timothy CornellFounder
What PreDxion Bio does
PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immune response following CAR-T therapy and predict the development of cytokine release syndrome and neurological AEs, and for use in guiding precision medicine approaches in critical care.
PreDxion Bio's YC application, reconstructed
Y Combinator application
PreDxion Bio, Summer 2017 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
PreDxion Bio
Rapid, scalable diagnostic for SARS-CoV-2 and beyond
We build a rapid antigen test that detects the SARS-CoV-2 spike protein from saliva, targeting asymptomatic and presymptomatic carriers. Our platform uses semiconductor fab processes allowing us to scale to tens of millions of tests in days. We originally started with sensors that monitor immune responses in critical care, now pivoting to large-scale infectious disease diagnostics.
We are based in South San Francisco now and plan to remain here after YC, to stay close to biotech and semiconductor partners.
South San Francisco situates us amid biotech and diagnostics companies, and semiconductor fabs nearby for scaling manufacturing. It's critical for integrating our microfluidics and nanosensor technology with existing infrastructure.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real PreDxion Bio YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from PreDxion Bio's public data (launch notes, founder backgrounds, product description). It shows how a company like PreDxion Bio would present itself to YC, not the text they submitted.
What YC batch was PreDxion Bio in?
PreDxion Bio was part of the Y Combinator Summer 2017 batch.
Who founded PreDxion Bio?
PreDxion Bio was founded by Walker McHugh, Timothy Cornell.
What does PreDxion Bio do?
Rapid, scalable diagnostic for SARS-CoV-2 and beyond
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of PreDxion Bio's application, and every other YC batch, is in YC Insights.
More YC startups like PreDxion Bio
